Sophia Watson is in urgent need of life-saving treatment for a tumor, but an insurance dispute has left her family without coverage.

Re: “ Judge temporarily blocks Trump move to cut NIH funding ” (Page A1, Feb. 11).

As part of the Daily Express's campaign for better mental health provisions for cancer patients, Robert Fisk offers a candid ...

The lead investigator for EV-302 said not long ago, survival of 12 to 14 months in this type of bladder cancer was considered ...

Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Weight loss drugs like Ozempic and Wegovy are all the rage, but not everyone can afford them, and not everyone needs them to ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

A new cancer breakthrough could prove to be a gamechanger for preventing the spread of breast cancer to other vital organs ...

The WHO’s cancer agency’s designation for hairstylists does not extend to people who dye their hair. That remains “not ...

The FDA previously designated the ADC as a breakthrough drug for relapsed or refractory ... At the moment, the first-line treatment is generally chemotherapy, with limited options for patients ...

Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...